EBD GmbH

  • Land: Schweiz

Nachricht vom 15.11.2018 | 14:00

Copenhagen welcomed over 4,200 life science executives last week at BIO-Europe 2018

DGAP-News: EBD Group / Key word(s): Conference

15.11.2018 / 14:00
The issuer is solely responsible for the content of this announcement.


Copenhagen welcomed over 4,200 life science executives last week at BIO-Europe(R) 2018

Munich, Germany and Copenhagen, Denmark - November 15, 2018: The highly successful twenty-fourth annual BIO-Europe(R) international partnering conference wrapped up in Copenhagen, Denmark, last week with a record-breaking 4,200+ attendees from the life sciences who engaged in over 26,000 one-to-one partnering meetings vying for 3,145 licensing opportunities on offer. The event welcomed 2,325 companies overall, including 450 delegates from Denmark and Sweden.

The event was produced by EBD Group in conjunction with Copenhagen Capacity, Invest in Skåne, LEO Pharma, Lundbeck Fonden, Novo Holdings, Novo Nordisk and Novozymes.

"We are very pleased with the overwhelming success of BIO-Europe in Copenhagen. Thank you to our hosts throughout the Medicon Valley of Denmark and southern Sweden for their invaluable help presenting this event to facilitate favorable deals among biotech, pharma and investment executives toward the development of therapies and cures," said Anna Chrisman, Managing Director of EBD Group and KNect365 Life Sciences. "We look forward to another great event in Hamburg, Germany, in 2019."

The local hosts Copenhagen Capacity and Invest in Skåne commented that they were "honored and happy to host BIO-Europe 2018 in Copenhagen and hope we got you so hooked that we will see you return in a couple of years to Scandinavia's strongest Life Science cluster Medicon Valley."

The event program highlighted pharma and VC collaborations, the microbiome, European biotech creation, new research in CNS, partnering opportunities with China, cell and gene therapies, digital medicine, and a Startup Slam highlighting the innovations of very early-stage biotech. Look for detailed coverage soon on Partnering Insight.

BIO-Europe(R) 2019 will be held in Hamburg, Germany, November 11-13, 2019, hosted by Life Science Nord.

"As we have seen again by the number of meetings this year in Copenhagen, BIO-Europe is of high importance for the life-science-sector," said Dr. Hinrich Habeck, Managing Director of Life Science Nord Management GmbH. "We are excited to be regional host of BIO-Europe in 2019 for the third time. The conference once again will provide the opportunity to present the Hamburg and Schleswig-Holstein life science region as an innovative, attractive and cosmopolitan location to more than 4,000 conference attendees."

For springtime partnering, be sure to consider BIO-Europe Spring(R) 2019, March 25-27 in Vienna, Austria.

# # #

About EBD Group

EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE(R), that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.

Today our events (BIO-Europe(R), BIO-Europe Spring(R), BioPharm America(TM), Biotech Showcase(TM), BioEquity Europe, ChinaBio(R) Partnering Forum, Cell & Gene Connect, Digital Medicine & Medtech Showcase and China Showcase) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.

Tune into EBD Group's Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. EBD Group is an Informa company. For more information please visit www.ebdgroup.com.

Media contact:

Kari Bennett, EBD Group: +1 760 930 0500; kbennett@ebdgroup.com

European media support

Anne Hennecke, MC Services AG: +49 211 529 252 22; anne.hennecke@mc-services.eu



15.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

Anleihe im Fokus

VST BUILDING TECHNOLOGIES AG: 7,00%-Anleihe 2019/2024 kann ab heute gezeichnet werden.

Emissionsvolumen der 5-jährigen Anleihe bis zu 15 Mio. Euro, Zeichnungsfrist vom 11.06.-25.06.2019


- WKN/ ISIN: A2R1SR / DE000A2R1SR7
- Stückelung: 1.000 Euro
- Kupon: 7,00 Prozent p.a. bei halbjährlicher Zinszahlung
- Zeichnungsfrist über Zeichnungsfunktionalität Börse Frankfurt voraussichtlich: 11 Juni 2019 bis 25 Juni 2019 (14:00 Uhr MESZ)
- Laufzeit: 28. Juni 2019 bis einschließlich 27. Juni 2024
- Rückzahlung: 28. Juni 2024
- Zinstermin: Halbjährlich

Interview im Fokus

„Schnelleres Wachstum mit Wasserstoff“

Mit dem Einstieg in die Wasserstoff-Technologie erschließt sich SFC Energy ein besonders dynamisches Segment. „Mittelfristig ist das Marktvolumen für Wasserstoff-Brennstoffzellen noch größer als im Direkt-Methanol-Bereich. Zivile Massenanwendungen könnten sich dabei zu einem echten Wachstumsbooster entwickeln“, ist CEO Dr. Peter Podesser überzeugt. Im Financial.de-Interview spricht der SFC-Vorstandschef u. a. über die aktuelle Euphorie für Brennstoffzellen-Aktien, die geplante Kapitalmaßnahme und das mittelfristige Umsatzziel von 100 Mio. Euro.

GBC-Fokusbox

Studie GBC Best of m:access I.2019: Weiter im Aufwind und mit starker Outperformance

Das Qualitätssegment m:access hat sich in den letzten Jahren fulminant entwickelt und ist auch 2018 weiter gewachsen. Zuletzt umfasste der m:access einen Rekordwert von 60 Unternehmen unterschiedlichster Branchen mit einer Gesamtmarktkapitalisierung von rund EUR 12 Mrd. Der von GBC berechnete m:access Index hat im Betrachtungszeitraum eine starke Outperformance gezeigt. Auch für die neue Top 15 Best-Of-Auswahl sind die Analysten wieder sehr positiv gestimmt. Die Studie steht kostenlos zum Download zur Verfügung.

News im Fokus

Infineon Technologies AG: Infineon setzt den Platzierungspreis für die neuen Aktien fest

17. Juni 2019, 23:59

Aktueller Webcast

Stealth BioTherapeutics

The BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

25. Juni 2019

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

19. Juni 2019